Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study

• Main Authors: Bacchi, P. (Author), Beach, S. (Author), Brunoni, A.R (Author), Busatto, G. (Author), Caruso, M.J.G (Author), Cincoto, A.V (Author), Damiano, R.F (Author), de Almeida Rocca, C.C (Author), de Pádua Serafim, A. (Author), Forlenza, O.V (Author), Fricchione, G. (Author), Guedes, B.F (Author), HCFMUSP COVID-19 Study Group (Author), Miguel, E.C (Author), Nitrini, R. (Author), Pan, P.M (Author)
• Format: Article
• Language: English
• Published: Elsevier Inc. 2022
• Subjects: adult; Adult; anxiety; Anxiety; Article; cognition; Cognition; cognitive defect; cohort analysis; Cohort Studies; Coronavirus; coronavirus disease 2019; COVID-19; depression; Depression; disease severity; epidemiology; female; generalized anxiety disorder; human; Humans; major clinical study; male; mental disease; mental health; Mental health; middle aged; morbidity; Morbidity; pandemic; PASC; posttraumatic stress disorder; prediction; psychometry; SARS-CoV-2; Sequelae; social psychology; social stress; structured interview
• Online Access: View Fulltext in Publisher

 Objective: The present study aims to investigate the occurrence of psychiatric and cognitive impairments in a cohort of survivors of moderate or severe forms of COVID-19. Method: 425 adults were assessed 6 to 9 months after hospital discharge with a structured psychiatric interview, psychometric tests and a cognitive battery. A large, multidisciplinary, set of clinical data depicting the acute phase of the disease, along with relevant psychosocial variables, were used to predict psychiatric and cognitive outcomes using the ‘Least Absolute Shrinkage and Selection Operator’ (LASSO) method. Results: Diagnoses of ‘depression’, ‘generalized anxiety disorder’ and ‘post-traumatic stress disorder’ were established respectively in 8%, 15.5% and 13.6% of the sample. After pandemic onset (i.e., within the previous year), the prevalence of ‘depression’ and ‘generalized anxiety disorder’ were 2.56% and 8.14%, respectively. Memory decline was subjectively reported by 51.1% of the patients. Psychiatric or cognitive outcomes were not associated with any clinical variables related to the severity of acute-phase disease, nor by disease-related psychosocial stressors. Conclusions: This is the first study to access rates of psychiatric and cognitive morbidity in the long-term outcome after moderate or severe forms of COVID-19 using standardized measures. As a key finding, there was no significant association between clinical severity in the acute-phase of SARS-CoV-2 infection and the neuropsychiatric impairment 6 to 9 months thereafter. © 2022 Elsevier Inc.